Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

CNTO-328 demonstrates anticancer activity in animals and humans

May 25, 2005

PRECISE trial awaits first futility analysis recommendation

May 25, 2005

Valentis gains rights to Del-1 antibody

May 24, 2005

Viragen discontinues development of IEP 11 peptide

May 24, 2005

Virulizin enhances IL-17E to propagate tumor destruction

May 23, 2005

Phase II data on MDX-010/dacarbazine combination therapy for metastatic melanoma

May 23, 2005

scFvCD7:sTRAIL causes restricted apoptosis in human leukemic T-cells

May 23, 2005

SPA for phase III GVAX prostate cancer trial

May 20, 2005

Bispecific T-cell engager MT-103 causes serial killing of target tumor cells

May 19, 2005

Bevacizumab plus chemotherapy improves survival in cancer patients

May 19, 2005

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...